Rovo A, Cantoni N, Samii K, Rufer A, et al. Real-world impact of primary immune thrombocytopenia and treatment with
thrombopoietin receptor agonists on quality of life based on patient-reported
experience: Results from a questionnaire conducted in Switzerland, Austria, and
Belgium. PLoS One 2022;17:e0267342.
PMID: 35446925